# Naltrexone Augmentation of Nicotine Patch Therapy - 1

> **NCT00218153** · PHASE3 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 200 (—)

## Conditions studied

- Tobacco Use Disorder

## Interventions

- **DRUG:** Naltrexone

## Key facts

- **NCT ID:** NCT00218153
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 200 (—)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00218153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00218153, "Naltrexone Augmentation of Nicotine Patch Therapy - 1". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00218153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*